Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Mesylate in Ph+ ALL
NCT00154349Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2003
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Novartis. Started Oct 2003; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00154349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154349.